Retatrutide is a next-generation synthetic peptide engineered to mimic the activity of multiple metabolic hormone pathways. It is designed as a triple receptor agonist, interacting with GLP-1, GIP, and glucagon receptors, making it a compound of significant interest in metabolic and endocrinology research.


Reviews
There are no reviews yet.